Hybrid Mobile-Cloud Computing: Driving the Future of Enterprise Mobility
Canada Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery
1. Canada Diabetes Care Devices Market Outlook to 2018-
Glucose Monitoring and Insulin Delivery
Report Details:
Published:September 2012
No. of Pages: 80
Price: Single User License – US$2500
Canada Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery
Summary
GlobalData’s new report, “Canada Diabetes Care Devices Market Outlook to 2018- Glucose
Monitoring and Insulin Delivery” provides key market data on the Canada Diabetes Care Devices
market. The report provides value (USD million), volume (units) and average price (USD) data for
each segment and sub-segment within two market categories – Glucose Monitoring and Insulin
Delivery. The report also provides company shares and distribution shares data for each of the
aforementioned market categories. The report is supplemented with global corporate-level profiles
of the key market participants with information on company financials and pipeline products,
wherever available.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for Diabetes Care Devices market categories – Glucose
Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for
each of the segments and sub-segments within two market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Canada Diabetes Care
Devicesmarket.
- Key players covered include Bayer HealthCare AG, LifeScan, Inc., F. Hoffmann-La Roche Ltd.,
Eli Lilly and Company, Abbott Laboratories, Novo Nordisk A/S and others.
2. Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Canada Diabetes Care
Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/197486-canada-diabetes-care-devices-market-outlook-to-2018-glucose-
monitoring-and-insulin-delivery.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 8
2.1 What is This Report About? 8
3 Diabetes Care Devices In Canada 9
3.1 Diabetes Care Devices, Market Segmentation 9
3.2 Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, 2004-2018 10
3.3 Diabetes Care Devices Market, Canada, Revenue Mix ($m), 2011 11
3.4 Diabetes Care Devices Market, Canada, Category Contribution (%), 2011 12
3.5 Diabetes Care Devices, Canada, Company Share (2010-2011) 17
4 Glucose Monitoring In Canada 19
4.1 Glucose Monitoring, Market Segmentation 19
4.2 Glucose Monitoring Market, Canada, Revenue Mix ($m), 2011 20
4.3 Glucose Monitoring Market, Canada, Segment Contribution (%), 2011 21
4.4 Glucose Monitoring Overall Revenue, (2004-2018) 22
4.4.1 Blood Glucose Meters, Revenue (2004-2018) 26
4.5 Glucose Monitoring Overall Volume (2004-2018) 29
4.5.1 Blood Glucose Meters, Volume (2004-2018) 31
4.6 Glucose Monitoring Average Price (2004-2018) 33
4.7 Glucose Monitoring Distribution Share (2010-2011) 34
4.8 Glucose Monitoring, Canada, Company Share (2010-2011) 35
5 Insulin Delivery In Canada 37
5.1 Insulin Delivery, Market Segmentation 37
5.2 Insulin Delivery Market, Canada, Revenue Mix ($m), 2011 38
3. 5.3 Insulin Delivery Market, Canada, Segment Contribution (%), 2011 39
5.4 Insulin Delivery Overall Revenue, (2004-2018) 40
5.4.1 Insulin Pens, Revenue (2004-2018) 44
5.4.2 Insulin Pumps, Revenue (2004-2018) 48
5.5 Insulin Delivery Overall Volume (2004-2018) 50
5.5.1 Insulin Pens, Volume (2004-2018) 54
5.5.2 Insulin Pumps, Volume (2004-2018) 58
5.6 Insulin Delivery Average Price (2004-2018) 60
5.7 Insulin Delivery Distribution Share (2010-2011) 61
5.8 Insulin Delivery, Canada, Company Share (2010-2011) 62
6 Overview of Key Companies in Canada Diabetes Care Devices Market 64
6.1 Bayer HealthCare AG 64
6.1.1 Company Overview 64
6.1.2 Share in the Canada Diabetes Care Devices Market 64
6.2 LifeScan, Inc. 65
6.2.1 Company Overview 65
6.2.2 Share in the Canada Diabetes Care Devices Market 65
6.3 F. Hoffmann-La Roche Ltd. 66
6.3.1 Company Overview 66
6.3.2 Share in the Canada Diabetes Care Devices Market 66
6.4 Eli Lilly and Company 67
6.4.1 Company Overview 67
6.4.2 Share in the Canada Diabetes Care Devices Market 67
6.5 Abbott Laboratories 68
6.5.1 Company Overview 68
6.5.2 Share in the Canada Diabetes Care Devices Market 68
6.6 Novo Nordisk A/S 69
6.6.1 Company Overview 69
6.6.2 Share in the Canada Diabetes Care Devices Market 69
6.7 Becton, Dickinson and Company 70
6.7.1 Company Overview 70
6.8 Sanofi 70
6.8.1 Company Overview 70
6.9 Medtronic, Inc. 70
6.9.1 Company Overview 70
6.10 Animas Corporation 71
6.10.1 Company Overview 71
7 Diabetes Care Devices Market Pipeline Products 72
8 Appendix 75
8.1 Definitions of Markets Covered in the Report 76
8.1.1 Diabetes Care Devices 76
8.2 Research Methodology 78
7. Market, 2011 66
Figure 40: Eli Lilly and Company, Company Share (%),Canada Diabetes Care Devices Market,
2011 67
Figure 41: Abbott Laboratories, Company Share (%),Canada Diabetes Care Devices Market, 2011
68
Figure 42: Novo Nordisk A/S, Dickinson and Company, Company Share (%),Canada Diabetes
Care Devices Market, 2011 69
Contact: sales@reportsandreports.com for more information.